PuSH - Publication Server of Helmholtz Zentrum München

365 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Yousri, N.A.* et al.: Long term conservation of human metabolic phenotypes and link to heritability. Catal. Lett. 10, 1005-1017 (2014)
Adamski, J. & Suhre, K.: Metabolomics platforms for genome wide association studies – linking the genome to the metabolom. Curr. Opin. Biotechnol. 24, 39-47 (2013)
Adamski, J.: 2nd congress on steroid research. J. Steroid Biochem. Mol. Biol. 137, 1-2 (2013)
Altmaier, E. et al.: Metabolomic profiles in individuals with negative affectivity and social inhibition: A population-based study of Type D personality. Psychoneuroendocrinology 38, 1299-1309 (2013)
Asciutto, G.* et al.: Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques. Cardiovasc. Pathol. 22, 438-443 (2013)
Boehm, A.A. et al.: Metabolic profiling of cultured human adipocytes from metabolically malign versus benign obese individuals. Diabetologia 56, S331 (2013)
Dharuri, H.* et al.: Automated wokflow-based exploitation of pathway databases provides new insights into genetic associations of metabolite profiles. BMC Genomics 14:865 (2013)
Ferrannini, E.* et al.: Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62, 1730-1737 (2013)
Floegel, A.* et al.: Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62, 639-648 (2013)
Floegel, A.* et al.: Variation of serum metabolites related to habitual diet: A targeted metabolomic approach in EPIC-Potsdam. Eur. J. Clin. Nutr. 67, 1100-1108 (2013)
Goek, O.-N.* et al.: Metabolites associate with kidney function decline and incident chronic kidney disease in the general population. Nephrol. Dial. Transplant. 28, 2131-2138 (2013)
Halama, A. ; Riesen, N. ; Hrabě de Angelis, M. & Adamski, J.: Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: Tolls for individualized medicine. J. Intern. Med. 274, 425-439 (2013)
Jaremek, M. et al.: Alcohol-induced metabolomic differences in humans. Transl. Psychiatry 3:e276 (2013)
Kugler, J.E.* et al.: High mobility group N proteins modulate the fidelity of the cellular transcriptional profile in a tissue- and variant-specific manner. J. Biol. Chem. 288, 16690-16703 (2013)
Lin, S.-X.* ; Poirier, D.* & Adamski, J.: A challenge for medicinal chemistry by the 17β-hydroxysteroid dehydrogenase superfamily: An integrated biological function and inhibition study. Curr. Top. Med. Chem. 13, 1164-1171 (2013)
Lotter, H.* et al.: Testosteron increases susceptibility to amebic liver abscess in mice and mediates inhibition of IFNγ secretion in natural killer T cells. PLoS ONE 8:e55694 (2013)
Ly, A. et al.: Retinal proteome alterations in a mouse model of type 2 diabetes. Diabetologia 57, 192-203 (2013)
Marchais-Oberwinkler, S.* et al.: Structural optimization of 2,5-tiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis. J. Med. Chem. 56, 167-181 (2013)
Menni, C.* et al.: Targeted metabolomics profiles are strongly correlated with nutritional patterns in women. Catal. Lett. 9, 506-514 (2013)
Neff, F. et al.: Rapamycin extends murine lifespan but has limited effects on aging. J. Clin. Invest. 123, 3272-3291 (2013)